Lazard Asset Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,225
| Closed | -$148K | – | 2553 |
|
|
2024
Q3 | $148K | Sell |
2,225
-1,536
| -41% | -$102K | ﹤0.01% | 1680 |
|
|
2024
Q2 | $251K | Buy |
3,761
+2,160
| +135% | +$144K | ﹤0.01% | 1489 |
|
|
2024
Q1 | $113K | Sell |
1,601
-84
| -5% | -$5.93K | ﹤0.01% | 1495 |
|
|
2023
Q4 | $141K | Buy |
1,685
+1,401
| +493% | +$117K | ﹤0.01% | 1519 |
|
|
2023
Q3 | $24K | Sell |
284
-1,405
| -83% | -$119K | ﹤0.01% | 2076 |
|
|
2023
Q2 | $157K | Hold |
1,689
| – | – | ﹤0.01% | 1419 |
|
|
2023
Q1 | $160K | Buy |
1,689
+71
| +4% | +$6.73K | ﹤0.01% | 1367 |
|
|
2022
Q4 | $162K | Buy |
1,618
+248
| +18% | +$24.8K | ﹤0.01% | 1345 |
|
|
2022
Q3 | $116K | Hold |
1,370
| – | – | ﹤0.01% | 1418 |
|
|
2022
Q2 | $117K | Buy |
1,370
+533
| +64% | +$45.5K | ﹤0.01% | 1461 |
|
|
2022
Q1 | $75K | Buy |
837
+147
| +21% | +$13.2K | ﹤0.01% | 1534 |
|
|
2021
Q4 | $69K | Hold |
690
| – | – | ﹤0.01% | 1594 |
|
|
2021
Q3 | $64K | Buy |
+690
| New | +$64K | ﹤0.01% | 1569 |
|
|
2021
Q2 | – | Sell |
-165
| Closed | -$14K | – | 2085 |
|
|
2021
Q1 | $14K | Hold |
165
| – | – | ﹤0.01% | 1755 |
|
|
2020
Q4 | $13K | Sell |
165
-292
| -64% | -$23K | ﹤0.01% | 1759 |
|
|
2020
Q3 | $36K | Sell |
457
-308
| -40% | -$24.3K | ﹤0.01% | 1285 |
|
|
2020
Q2 | $67K | Hold |
765
| – | – | ﹤0.01% | 1141 |
|
|
2020
Q1 | $71K | Buy |
765
+584
| +323% | +$54.2K | ﹤0.01% | 1077 |
|
|
2019
Q4 | $19K | Buy |
181
+162
| +853% | +$17K | ﹤0.01% | 1250 |
|
|
2019
Q3 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 1444 |
|
|
2019
Q2 | – | Sell |
-155,262
| Closed | -$13.7M | – | 1253 |
|
|
2019
Q1 | $13.7M | Sell |
155,262
-32,100
| -17% | -$2.83M | 0.02% | 367 |
|
|
2018
Q4 | $15.6M | Buy |
187,362
+6,600
| +4% | +$548K | 0.03% | 320 |
|
|
2018
Q3 | $17M | Buy |
180,762
+42,500
| +31% | +$4M | 0.03% | 334 |
|
|
2018
Q2 | $15.2M | Buy |
138,262
+25,462
| +23% | +$2.8M | 0.03% | 346 |
|
|
2018
Q1 | $11.2M | Buy |
+112,800
| New | +$11.2M | 0.02% | 413 |
|